DK0831837T3 - Anvendelse af squalamin i fremstilling af et medikament til inhibering af NHE - Google Patents
Anvendelse af squalamin i fremstilling af et medikament til inhibering af NHEInfo
- Publication number
- DK0831837T3 DK0831837T3 DK96919096T DK96919096T DK0831837T3 DK 0831837 T3 DK0831837 T3 DK 0831837T3 DK 96919096 T DK96919096 T DK 96919096T DK 96919096 T DK96919096 T DK 96919096T DK 0831837 T3 DK0831837 T3 DK 0831837T3
- Authority
- DK
- Denmark
- Prior art keywords
- compounds
- inhibitors
- nhe
- squalamine
- medicament
- Prior art date
Links
- UIRKNQLZZXALBI-MSVGPLKSSA-N Squalamine Chemical compound C([C@@H]1C[C@H]2O)[C@@H](NCCCNCCCCN)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@H](C)CC[C@H](C(C)C)OS(O)(=O)=O)[C@@]2(C)CC1 UIRKNQLZZXALBI-MSVGPLKSSA-N 0.000 title 1
- UIRKNQLZZXALBI-UHFFFAOYSA-N Squalamine Natural products OC1CC2CC(NCCCNCCCCN)CCC2(C)C2C1C1CCC(C(C)CCC(C(C)C)OS(O)(=O)=O)C1(C)CC2 UIRKNQLZZXALBI-UHFFFAOYSA-N 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 230000002401 inhibitory effect Effects 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 229950001248 squalamine Drugs 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 5
- 239000003112 inhibitor Substances 0.000 abstract 3
- 238000000034 method Methods 0.000 abstract 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 abstract 1
- 238000003556 assay Methods 0.000 abstract 1
- 238000012216 screening Methods 0.000 abstract 1
- 229910052708 sodium Inorganic materials 0.000 abstract 1
- 239000011734 sodium Substances 0.000 abstract 1
- 238000001228 spectrum Methods 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/474,799 US5792635A (en) | 1995-06-07 | 1995-06-07 | Method of inhibiting the sodium/proton exchanger NHE3 and method of inhibiting growth by administering squalamine |
PCT/US1996/008954 WO1996040151A1 (en) | 1995-06-07 | 1996-06-07 | Use of squalamine for the manufacture of a medicament for inhibiting nhe |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0831837T3 true DK0831837T3 (da) | 2003-08-25 |
Family
ID=23884982
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK96919096T DK0831837T3 (da) | 1995-06-07 | 1996-06-07 | Anvendelse af squalamin i fremstilling af et medikament til inhibering af NHE |
Country Status (12)
Country | Link |
---|---|
US (1) | US5792635A (da) |
EP (1) | EP0831837B1 (da) |
JP (1) | JP4077512B2 (da) |
AT (1) | ATE238800T1 (da) |
AU (1) | AU712436B2 (da) |
CA (1) | CA2223908C (da) |
DE (1) | DE69627853T2 (da) |
DK (1) | DK0831837T3 (da) |
ES (1) | ES2201187T3 (da) |
PT (1) | PT831837E (da) |
WO (1) | WO1996040151A1 (da) |
ZA (1) | ZA964819B (da) |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5856535A (en) * | 1994-08-18 | 1999-01-05 | Magainin Pharmaceuticals, Inc. | Aminosterol ester compounds |
US5847172A (en) * | 1995-06-07 | 1998-12-08 | Magainin Pharmaceuticals Inc. | Certain aminosterol compounds and pharmaceutical compositions including these compounds |
CA2222484C (en) | 1995-06-07 | 2008-03-18 | Conceptus, Inc. | Contraceptive transcervical fallopian tube occlusion devices having mechanical fallopian tube attachment |
US6143738A (en) * | 1995-06-07 | 2000-11-07 | Magainin Pharmaceuticals, Inc. | Therapeutic uses for an aminosterol compound |
JP2000510460A (ja) * | 1996-04-26 | 2000-08-15 | マゲイニン・ファーマシューティカルズ・インコーポレーテッド | スクアラミンを他の抗癌剤と併用する上皮性悪性腫瘍の治療 |
US6596712B2 (en) | 1996-04-26 | 2003-07-22 | Genaera Corporation | Treatment of carcinomas using squalamine in combination with other anti-cancer agents or modalities |
EP0923377A1 (en) * | 1996-05-17 | 1999-06-23 | Magainin Pharmaceuticals Inc. | Therapeutic uses for an aminosterol compound |
US7410959B1 (en) * | 2000-07-13 | 2008-08-12 | Genaera Corporation | Therapeutic uses for aminosterol compounds |
AU5194998A (en) * | 1996-11-01 | 1998-05-29 | Magainin Pharmaceuticals, Inc. | Certain aminosterol compounds and uses therefor |
US6262283B1 (en) | 1996-12-06 | 2001-07-17 | Magainin Pharmaceuticals Inc. | Stereoselective synthesis of 24-hydroxylated compounds useful for the preparation of aminosterols, vitamin D analogs, and other compounds |
DE69929177T2 (de) * | 1998-03-26 | 2006-08-24 | Phytopharm Plc, Godmanchester | Smilagenin und anzurogenin-d zur behandlung der alzheimerischen krankheit |
GB9923076D0 (en) * | 1999-09-29 | 1999-12-01 | Phytopharm Plc | Sapogenin derivatives and their use |
DE19849722A1 (de) * | 1998-10-28 | 2000-05-04 | Aventis Pharma Gmbh | Substituierte Phenyl-alkenoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
GB9923078D0 (en) * | 1999-09-29 | 1999-12-01 | Phytopharm Plc | Sapogenin derivatives and their use |
GB9923077D0 (en) * | 1999-09-29 | 1999-12-01 | Phytopharm Plc | Sapogenin derivatives and their use |
JP2004506599A (ja) * | 1999-12-09 | 2004-03-04 | ジェネーラ・コーポレーション | 喘息および関連疾患を含むアトピー性アレルギーを処置するための標的としての喘息関連因子 |
DE19960204A1 (de) * | 1999-12-14 | 2001-06-28 | Aventis Pharma Gmbh | Substituierte Norlbornylamino-Derivate, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
AU5342701A (en) | 2000-04-12 | 2001-10-30 | Genaera Corp | A process for the preparation of 7.alpha.-hydroxy 3-aminosubstituted sterols using intermediates with an unprotected 7.alpha.-hydroxy group |
GB0107822D0 (en) * | 2001-03-28 | 2001-05-23 | Phytopharm Plc | Sapogenin derivatives their synthesis and use methods based upon their use |
CN102727501A (zh) * | 2002-03-27 | 2012-10-17 | 菲特法姆股份有限公司 | 皂角苷配基及其衍生物的用途 |
US20050130948A1 (en) * | 2002-03-27 | 2005-06-16 | Daryl Rees | Therapeutic methods and uses of sapogenins and their derivatives |
ES2732251T3 (es) | 2005-04-25 | 2019-11-21 | Enterin Inc | Dilactato de escualamina cristalino |
EP2051716A1 (en) * | 2006-04-21 | 2009-04-29 | Genaera Corporation | Induction of weight loss and the selective inhibition of ptp1b |
TW200927755A (en) * | 2007-09-06 | 2009-07-01 | Genaera Corp | A method for treating diabetes |
US20120088737A2 (en) * | 2009-10-02 | 2012-04-12 | Ajinomoto Co., Inc | Novel acyl guanidine derivatives |
US8729058B2 (en) | 2009-10-27 | 2014-05-20 | Michael Zasloff | Methods and compositions for treating and preventing viral infections |
US8623416B2 (en) * | 2009-11-25 | 2014-01-07 | Michael Zasloff | Formulations comprising aminosterols |
PL2838907T3 (pl) * | 2012-04-20 | 2019-12-31 | Ohr Pharmaceutical, Inc. | Aminosteroidy do leczenia choroby związanej z PTP1B |
JP6255082B2 (ja) * | 2013-03-13 | 2017-12-27 | セージ セラピューティクス, インコーポレイテッド | 神経刺激性ステロイドおよびその使用方法 |
US10040817B2 (en) * | 2013-10-03 | 2018-08-07 | Enterin Laboratories, Inc. | Methods and compositions for stimulation of the intestinal enteroendocrine system for treating diseases or conditions related to the same |
KR20180026742A (ko) | 2015-07-06 | 2018-03-13 | 세이지 테라퓨틱스, 인크. | 옥시스테롤 및 그의 사용 방법 |
BR112018070123A2 (pt) | 2016-04-01 | 2019-02-05 | Sage Therapeutics Inc | oxiesterós e métodos de uso dos mesmos |
WO2017193046A1 (en) | 2016-05-06 | 2017-11-09 | Sage Therapeutics, Inc. | Oxysterols and methods of use thereof |
MA46351A (fr) | 2016-09-30 | 2021-06-02 | Sage Therapeutics Inc | Oxystérols substitués en c7 et procédés en tant que modulateurs nmda |
CN115181153A (zh) | 2016-10-18 | 2022-10-14 | 萨奇治疗股份有限公司 | 氧甾醇及其使用方法 |
MA50094A (fr) | 2017-09-08 | 2020-07-15 | Enterin Inc | Méthodes de traitement des troubles du sommeil, des perturbations du sommeil et de symptômes associés à l'aide de compositions d'aminostérol |
Family Cites Families (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3016390A (en) * | 1960-06-30 | 1962-01-09 | Searle & Co | N-(substituted alkyl) amino-5alpha-androstan-17beta-ols |
US3370070A (en) * | 1965-06-16 | 1968-02-20 | Searle & Co | [n-alkyl-17-(dialkylaminoalkyl)amino] androst-4-en-3-ones |
GB1565351A (en) * | 1975-06-02 | 1980-04-16 | Theramex | Steroid aminoethers |
US4220598A (en) * | 1977-11-14 | 1980-09-02 | Abbott Laboratories | Method and reagents for measuring the level of conjugated bile acids |
US4550163A (en) * | 1979-02-05 | 1985-10-29 | Abbott Laboratories | Ligand analog-irreversible enzyme inhibitor conjugates |
US4372888A (en) * | 1980-08-26 | 1983-02-08 | The United States Of America As Represented By The Secretary Of The Department Of Health & Human Services | Nondenaturing zwitterionic detergents |
JPS5842878B2 (ja) * | 1981-12-02 | 1983-09-22 | 名糖産業株式会社 | 12−オキソコラン酸トシルヒドラゾン化合物、その製法ならびに利用 |
EP0101554B1 (en) * | 1982-07-29 | 1986-10-15 | Lehner A.G. | New derivatives of biliary acids, process for the production thereof and pharmaceutical compositions containing the same |
US4994443A (en) * | 1982-12-20 | 1991-02-19 | The Children's Medical Center Corporation | Inhibition of angiogenesis |
US5001116A (en) * | 1982-12-20 | 1991-03-19 | The Children's Medical Center Corporation | Inhibition of angiogenesis |
IT1221734B (it) * | 1983-02-24 | 1990-07-12 | Schiena Michele Giuseppe Di | Ursodesossicolico solfato acido sale sodico |
US4545938A (en) * | 1983-11-02 | 1985-10-08 | Beth Israel Medical Center | Chemical synthesis |
WO1987002367A2 (en) * | 1985-10-18 | 1987-04-23 | The Upjohn Company | Cyclic hydrocarbons with an aminoalkyl sidechain |
US4771042A (en) * | 1985-11-25 | 1988-09-13 | The Upjohn Company | Inhibition of angiogenesis involving the coadministration of steroids with heparin or heparin fragments |
JPS62175497A (ja) * | 1986-01-28 | 1987-08-01 | Wakunaga Pharmaceut Co Ltd | 胆汁酸誘導体およびその製造法 |
US5075464A (en) * | 1987-04-22 | 1991-12-24 | Merrell Dow Pharmaceuticals Inc. | 17β-(cyclopropylamino)androstene derivatives |
SE8702254D0 (sv) * | 1987-05-29 | 1987-05-29 | Kabivitrum Ab | Novel heparin derivatives |
US5135919A (en) * | 1988-01-19 | 1992-08-04 | Children's Medical Center Corporation | Method and a pharmaceutical composition for the inhibition of angiogenesis |
IT1229570B (it) * | 1989-04-17 | 1991-09-04 | Giuliani Spa | Derivati fluorurati di acidi biliari, loro preparazione e composizioni farmaceutiche che li contengono. |
IT1229569B (it) * | 1989-04-17 | 1991-09-04 | Giuliani Spa | Derivati di acidi biliari, loro preparazione e composizioni farmaceutiche che li contengono. |
JPH07116215B2 (ja) * | 1989-04-19 | 1995-12-13 | エスエス製薬株式会社 | 新規なステロイド化合物 |
PT93847A (pt) * | 1989-04-24 | 1990-11-20 | Harvard College | Processo para a preparacao de oligossacaridos de baixo peso molecular derivados de heparina ou de sulfato de heparano despolimerizados e de composicoes farmaceuticas que os contem |
US4966897A (en) * | 1989-08-15 | 1990-10-30 | Merrell Dow Pharmaceuticals Inc. | 4-substituted 17β-(cyclopropyloxy)androst-5-en-3β-ol and related compounds useful as C17-20 lyase inhibitors |
US5004737A (en) * | 1989-09-22 | 1991-04-02 | Pacific Chemical Co., Ltd. | Quaternary ammonium-substituted sterol derivatives |
EP0466315A3 (en) * | 1990-05-30 | 1992-07-01 | Larrian Gillespie | Compositions containing xylan sulphates for affecting growth factor function and for inhibiting fibroblast proliferation |
DE69132048T2 (de) * | 1990-06-11 | 2000-07-13 | Alcon Lab Inc N D Ges D Staate | Verwendung von Steroiden zur Inhibierung von Angiogenesis |
US5250524A (en) * | 1990-12-06 | 1993-10-05 | Hoechst Aktiengesellschaft | Bile acid derivatives, process for their preparation and use of these compounds as pharmaceuticals |
US5192756A (en) * | 1992-03-18 | 1993-03-09 | The Children's Hospital Of Pennsylvania | Aminosterol antibiotic |
EP0647133A4 (en) * | 1992-06-12 | 1997-10-29 | Affymax Tech Nv | COMPOSITIONS AND METHODS FOR IMPROVED DRUG DELIVERY. |
AU6392894A (en) * | 1993-02-26 | 1994-09-14 | Magainin Pharmaceuticals, Inc. | Chemical synthesis of squalamine |
JP3546886B2 (ja) * | 1993-03-10 | 2004-07-28 | ジェネーラ コーポレーション | ステロイド誘導体、それらを含む薬剤組成物、及び抗生物質又は消毒薬としてのそれらの使用 |
CA2185123C (en) * | 1994-03-10 | 2010-11-16 | Leah L. Frye | Steroid derivatives, pharmaceutical compositions containing them, and their pharmaceutical uses |
DE69631527T2 (de) * | 1995-06-07 | 2004-09-23 | Genaera Corp. | Aminosterinverbindungen als inhibitoren der natrium/proton-pump, pharmazeutische methoden und präparaten davon |
-
1995
- 1995-06-07 US US08/474,799 patent/US5792635A/en not_active Expired - Fee Related
-
1996
- 1996-06-07 CA CA002223908A patent/CA2223908C/en not_active Expired - Lifetime
- 1996-06-07 ES ES96919096T patent/ES2201187T3/es not_active Expired - Lifetime
- 1996-06-07 AT AT96919096T patent/ATE238800T1/de not_active IP Right Cessation
- 1996-06-07 AU AU61528/96A patent/AU712436B2/en not_active Ceased
- 1996-06-07 WO PCT/US1996/008954 patent/WO1996040151A1/en active IP Right Grant
- 1996-06-07 EP EP96919096A patent/EP0831837B1/en not_active Expired - Lifetime
- 1996-06-07 PT PT96919096T patent/PT831837E/pt unknown
- 1996-06-07 DE DE69627853T patent/DE69627853T2/de not_active Expired - Fee Related
- 1996-06-07 DK DK96919096T patent/DK0831837T3/da active
- 1996-06-07 ZA ZA9604819A patent/ZA964819B/xx unknown
- 1996-06-07 JP JP50139797A patent/JP4077512B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
AU712436B2 (en) | 1999-11-04 |
DE69627853D1 (de) | 2003-06-05 |
DE69627853T2 (de) | 2004-02-19 |
JP4077512B2 (ja) | 2008-04-16 |
US5792635A (en) | 1998-08-11 |
ES2201187T3 (es) | 2004-03-16 |
AU6152896A (en) | 1996-12-30 |
ATE238800T1 (de) | 2003-05-15 |
PT831837E (pt) | 2003-09-30 |
EP0831837B1 (en) | 2003-05-02 |
ZA964819B (en) | 1998-02-09 |
CA2223908A1 (en) | 1996-12-19 |
EP0831837A1 (en) | 1998-04-01 |
WO1996040151A1 (en) | 1996-12-19 |
CA2223908C (en) | 2007-02-20 |
JPH11506775A (ja) | 1999-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0831837T3 (da) | Anvendelse af squalamin i fremstilling af et medikament til inhibering af NHE | |
WO1996040728A3 (en) | Aminosterol compounds useful as inhibitors of the sodium/proton exchanger (nhe), pharmaceutical methods and compositions employing such inhibitors, and processes for evaluating the nhe-inhibitory efficacy of compounds | |
TR200001603T2 (tr) | Yeni bileşikler | |
DK550188D0 (da) | Antigestagen- og antioestrogenvirksomme forbindelser til behandling af hormonafhaengige tumorer | |
TR200102800T2 (tr) | Yeni bileşikler. | |
TR199701574T2 (xx) | �midazol bile�imleri | |
ES2186783T3 (es) | Derivados de la dolastatina, su preparacion y uso. | |
SE9504661D0 (sv) | New compounds | |
ES2193252T3 (es) | Quinolonas y su uso terapeutico. | |
DK125796A (da) | I form af små molekyler foreliggende inhibitorer for rotamaseaktivitet | |
ES2189235T3 (es) | 6-fenilfenantridinas sustituidas. | |
TR199801255T2 (xx) | Vitronektin resept�r antagonistleri. | |
ATE228111T1 (de) | M-amidinophenyl-analoga als faktor-xa-inhibitoren | |
DK0767798T3 (da) | Sterolderivater anvendt til regulering af meiose | |
DE69926919D1 (de) | N-ureidoalkylpiperidine als modulatoren der aktivität der chemokinrezeptoren | |
TR200003377T2 (tr) | Estrojenler ile bütünleşik 2-fenil-1-[4-(2-aminoetoksi)benzil]-indol | |
NO975557D0 (no) | Immortalisering og dismortalisering av celler | |
TR199900310T2 (xx) | Trombin inhibit�rleri | |
DE69523622D1 (de) | Diastereomerenreine 3-oxo und 3-thioxo-4-aza-androstanderivate und ihre verwendung als antiandrogene | |
CO5040088A1 (es) | Nuevos compuestos y usos anestesicos locales | |
DE3583189D1 (de) | Carbazole und ihre verwendung als photoinitiatoren von photopolymerisierbaren, ungesaettigten verbindungen. | |
DK0639275T3 (da) | Hidtil ukendte GABAa-receptorundertyper og fremgangsmåder til screening af lægemiddelforbindelser under anvendelse af imidazoquinoxaliner og pyrrolopyimidiner til binding til GABAa-receptorundertyper | |
DE59108770D1 (de) | Fluorverbindungen als Aromatase-Inhibitoren | |
FI955118A (fi) | Herbisidiset substituoidut 1-fenyyli- tai 1-pyridinyyli-bentsotriatsolit | |
SE9504662D0 (sv) | New compounds |